FDA approves Waskyra for Wiskott-Aldrich syndrome
The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).
Dec 16, 2025
0
10
MeSH tree: C15.378.243
The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).
Dec 16, 2025
0
10
A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were treated with proton therapy (IMPT) compared to those treated with traditional radiation therapy (IMRT).
Dec 11, 2025
0
44
Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard therapy went longer without a bleeding episode that needed urgent treatment or needing another treatment ...
Dec 9, 2025
0
9
Biliary tract cancers, including intrahepatic, perihilar, and extrahepatic cholangiocarcinoma and gallbladder cancer, are among the most aggressive gastrointestinal malignancies. Treatment options remain limited once the ...
Nov 28, 2025
0
14
Several raw milk cheeses from a Washington creamery are being recalled after links to E. coli infections in two states.
Nov 24, 2025
0
14
A new study by investigators from Mass General Brigham suggests that heavy alcohol use may lead to more severe brain bleeds and cause long-term brain vessel damage at a younger age.
Nov 5, 2025
0
21
When you open the refrigerator and find a wedge of cheese flecked with green mold, or a package of chicken that smells faintly sour, it can be tempting to gamble with your stomach rather than waste food.
Oct 28, 2025
0
15
A new study in the Journal of Hepatology reports on an auxiliary liver xenotransplant from a genetically engineered pig to a living human recipient.
Oct 9, 2025
0
27
Previously, results from the photon cohort of the NRG-BN001, a signal seeking Phase II randomized trial, indicated that photon radiation dose intensification (75 Gy) did not demonstrate improvement in overall survival (OS) ...
Oct 1, 2025
0
14
Red blood cells, long thought to be passive bystanders in the formation of blood clots, actually play an active role in helping clots contract, according to a new study by researchers at the University of Pennsylvania.
Aug 6, 2025
0
85